Oxidation-induced lymphocyte transformation.
D000429:Alcohol Oxidoreductases / Q000494:pharmacology*; D000961:Antilymphocyte Serum; D001402:B-Lymphocytes / Q000187:drug effects; D001894:Borohydrides / Q000494:pharmacology; D002448:Cell Adhesion; D002449:Cell Aggregation; D002462:Cell Membrane / Q000187:drug effects; D005692:Galactose Oxidase / Q000494:pharmacology*; D006898:Hydroxylamines / Q000494:pharmacology; D007938:Leukemia; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008937:Mitomycins / Q000494:pharmacology; D009439:Neuraminidase / Q000494:pharmacology*; D010504:Periodic Acid / Q000494:pharmacology*; D012663:Semicarbazides / Q000494:pharmacology; D012794:Sialic Acids / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects
D000961:Antilymphocyte Serum; D001894:Borohydrides; D006898:Hydroxylamines; D008937:Mitomycins; D012663:Semicarbazides; D012794:Sialic Acids; D010504:Periodic Acid; D000429:Alcohol Oxidoreductases; D005692:Galactose Oxidase; D009439:Neuraminidase